| CTRI Number |
CTRI/2024/07/071002 [Registered on: 22/07/2024] Trial Registered Prospectively |
| Last Modified On: |
08/07/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
A study of chronic kidney disease in a rural area in India |
|
Scientific Title of Study
|
Clinico Epidemiological Profile of Patients with CKDu in a Tertiary Care Centre in a Rural Area in Central India |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Shubham Dubey |
| Designation |
Senior Resident |
| Affiliation |
Datta Meghe Institute of Higher Education and Research |
| Address |
Department of Nephrology, Third Floor, Ward No 30, AVBRH Building, Sawangi Meghe
Wardha MAHARASHTRA 442001 India |
| Phone |
9425393182 |
| Fax |
|
| Email |
shubham_dubey@rediffmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Manish Balwani |
| Designation |
Professor and Head of the Department |
| Affiliation |
Datta Meghe Institute of Higher Education and Research |
| Address |
Department of Nephrology, Third Floor, Ward No 30, AVBRH Building, Sawangi Meghe
Wardha MAHARASHTRA 442001 India |
| Phone |
9924980546 |
| Fax |
|
| Email |
balwani.manish@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Shubham Dubey |
| Designation |
Senior Resident |
| Affiliation |
Datta Meghe Institute of Higher Education and Research |
| Address |
Department of Nephrology, Third Floor, Ward No 30, AVBRH Building, Sawangi Meghe
Wardha MAHARASHTRA 442001 India |
| Phone |
9425393182 |
| Fax |
|
| Email |
shubham_dubey@rediffmail.com |
|
|
Source of Monetary or Material Support
|
| Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha, Maharashtra, India. 442001 |
|
|
Primary Sponsor
|
| Name |
Datta Meghe Institute of Higher Education and Research |
| Address |
Sawangi, Wardha, Maharashtra, India. 442001 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Shubham Dubey |
Datta Meghe Institute of Higher Education and Research |
Department of Nephrology, Ward number 29/30, 3rd floor, Acharya Vinoba Bhave Rural Hospital and Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra, India. 442001 Wardha MAHARASHTRA |
9425393182
shubham_dubey@rediffmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Datta Meghe Institute of Higher Education and Research |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: N189||Chronic kidney disease, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
NIL |
NIL |
| Intervention |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
All patients of Chronic Kidney Disease between the age of 18 years and 70 years with estimated glomerular filtration rate (eGFR) by creatinine-based CKD Epidemiology Collaboration (CKD-EPIcr2009)equation of 5 mL/min/1.73m2 to 60 mL/min/1.73m2. Patients voluntarily willing to give informed consent will be taken for this study. |
|
| ExclusionCriteria |
| Details |
Patients less than 18 years of age. Patients with other known causes of CKD. Organ transplant recipients. Patients with malignancy. Pregnant females. Patients on current immunosuppressive therapy.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
The primary outcome of the study could be
defined as the study of the clinical and epidemiological profile of patients with CKD of Undetermined Etiology(CKDu). |
Baseline and 12 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Secondary outcomes include the study of various biochemical and radiological parameters in patients of CKD of Undetermined Etiology(CKDu).
|
12 weeks |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
05/09/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The study proposes to study the clinico-epidemiological profile and investigate various biochemical and radiological parameters in patients with chronic kidney disease of Undetermined Etiology (CKDu) in a tertiary care centre in a rural area in Central India. The rationale underscores the importance of understanding the relationship between various epidemiological factors and occurrence of CKDu. The objectives include evaluating various clinical features and epidemiological factors associated with CKDu. Ethical approval and informed consent will be obtained, with data collected through patient history, examination, and laboratory tests. Statistical analysis will be conducted using SPSS software. The study aims to contribute valuable insights into the epidemiological features associated with CKDu patients, potentially informing preventive and clinical management strategies. |